Eton Pharmaceuticals reported a record Q3 2026 revenue of $57.9 million, a 158% increase year-over-year, surpassing its $200 million annualized revenue goal five quarters early. The company also achieved a strong adjusted EBITDA margin of 49% and raised its 2026 revenue guidance to over $175 million, up from $145 million. Key product sales and active patient counts grew significantly, and the company advanced its pipeline with new programs and regulatory submissions. Eton plans to launch new products in 2027, including LIBERVANT, expanding into neurology, and continues to invest in rare disease treatments.
Eton Pharmaceuticals reported a record Q3 2026 revenue of $57.9 million, a 158% increase year-over-year. For readers following the health sector, here is Pluang's market snapshot as of Nov 06, 2026 04:11 WIB: out of 150 priced US health stocks, 16 rose and 134 fell. Notable movers include SELLAS Life Sciences Group Inc. (SLS) at USD 7.85 with a -14.11% change, Cytokinetics Inc (CYTK) at USD 55.45 with -12.82% and 100% buy order activity, and Nuwellis Inc (NUWE) at USD 4.60 with -12.71% and 100% buy order activity.
The 2026 Global Health Congress in New York gathered over 625 healthcare leaders from 25 countries to discuss innovation, equity, and investment in healthcare. The event featured 350+ startup applications in its Healthcare Shark Tank competition, cro...
Ambarella, an edge AI semiconductor company, announced its third quarter fiscal year 2027 earnings conference call will be held on November 24, 2026, at 1:30 p.m. Pacific Time. The company will release its earnings report after the market closes that...
Binance experienced a net outflow of 439 million USDT over a 24-hour period, indicating that more Tether stablecoins were withdrawn from the exchange than deposited. This net outflow reflects a shift in user activity that could impact liquidity and t...
Bitcoin has experienced a 46% decline from its previous all-time high near $80,000, and current cycle indicators suggest it remains in a correction phase. Key metrics like the 30-day moving average of the cycle-extremes index and a cycle-extremes osc...
At Devcon, a demo showed a trader executing a single order on an experimental Ethereum rollup network, with the trade filled using liquidity from the Ethereum mainnet and tokens returned to the rollup. This approach allows traders to access deeper li...
